460 related articles for article (PubMed ID: 33111402)
1. Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease.
Tan MMX; Lawton MA; Jabbari E; Reynolds RH; Iwaki H; Blauwendraat C; Kanavou S; Pollard MI; Hubbard L; Malek N; Grosset KA; Marrinan SL; Bajaj N; Barker RA; Burn DJ; Bresner C; Foltynie T; Wood NW; Williams-Gray CH; Hardy J; Nalls MA; Singleton AB; Williams NM; Ben-Shlomo Y; Hu MTM; Grosset DG; Shoai M; Morris HR
Mov Disord; 2021 Feb; 36(2):424-433. PubMed ID: 33111402
[TBL] [Abstract][Full Text] [Related]
2. The Parkinson's Disease Genome-Wide Association Study Locus Browser.
Grenn FP; Kim JJ; Makarious MB; Iwaki H; Illarionova A; Brolin K; Kluss JH; Schumacher-Schuh AF; Leonard H; Faghri F; Billingsley K; Krohn L; Hall A; Diez-Fairen M; Periñán MT; Foo JN; Sandor C; Webber C; Fiske BK; Gibbs JR; Nalls MA; Singleton AB; Bandres-Ciga S; Reed X; Blauwendraat C;
Mov Disord; 2020 Nov; 35(11):2056-2067. PubMed ID: 32864809
[TBL] [Abstract][Full Text] [Related]
3. Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts.
Iwaki H; Blauwendraat C; Leonard HL; Kim JJ; Liu G; Maple-Grødem J; Corvol JC; Pihlstrøm L; van Nimwegen M; Hutten SJ; Nguyen KH; Rick J; Eberly S; Faghri F; Auinger P; Scott KM; Wijeyekoon R; Van Deerlin VM; Hernandez DG; Gibbs JR; ; Chitrala KN; Day-Williams AG; Brice A; Alves G; Noyce AJ; Tysnes OB; Evans JR; Breen DP; Estrada K; Wegel CE; Danjou F; Simon DK; Andreassen O; Ravina B; Toft M; Heutink P; Bloem BR; Weintraub D; Barker RA; Williams-Gray CH; van de Warrenburg BP; Van Hilten JJ; Scherzer CR; Singleton AB; Nalls MA
Mov Disord; 2019 Dec; 34(12):1839-1850. PubMed ID: 31505070
[TBL] [Abstract][Full Text] [Related]
4. Association of PICALM with Cognitive Impairment in Parkinson's Disease.
Periñán MT; Macías-García D; Labrador-Espinosa MÁ; Jesús S; Buiza-Rueda D; Adarmes-Gómez AD; Muñoz-Delgado L; Gómez-Garre P; Mir P
Mov Disord; 2021 Jan; 36(1):118-123. PubMed ID: 32914893
[TBL] [Abstract][Full Text] [Related]
5. X-Chromosome Association Study in Latin American Cohorts Identifies New Loci in Parkinson's Disease.
Leal TP; Rao SC; French-Kwawu JN; Gouveia MH; Borda V; Bandres-Ciga S; Inca-Martinez M; Mason EA; Horimoto ARVR; Loesch DP; Sarihan EI; Cornejo-Olivas MR; Torres LE; Mazzetti-Soler PE; Cosentino C; Sarapura-Castro EH; Rivera-Valdivia A; Medina AC; Dieguez EM; Raggio VE; Lescano A; Tumas V; Borges V; Ferraz HB; Rieder CR; Schumacher Schuh A; Santos-Lobato BL; Velez-Pardo C; Jimenez-Del-Rio M; Lopera F; Moreno S; Chana-Cuevas P; Fernandez W; Arboleda G; Arboleda H; Arboleda Bustos CE; Yearout D; Barbosa MT; Cardoso FEC; Caramelli P; Cunningham MCQ; Maia DP; Lima-Costa MF; Tarazona-Santos E; Zabetian CP; ; Thornton TA; O'Connor TD; Mata IF;
Mov Disord; 2023 Sep; 38(9):1625-1635. PubMed ID: 37469269
[TBL] [Abstract][Full Text] [Related]
6. An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele.
Shahid M; Kim J; Leaver K; Hendershott T; Zhu D; Cholerton B; Henderson VW; Tian L; Poston KL
Neurobiol Dis; 2019 Jul; 127():278-286. PubMed ID: 30826425
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.
Simuni T; Brumm MC; Uribe L; Caspell-Garcia C; Coffey CS; Siderowf A; Alcalay RN; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Nudelman K; Tosun-Turgut D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten S; Bressman S; Marek K;
Mov Disord; 2020 May; 35(5):833-844. PubMed ID: 32073681
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease.
Fiorenzato E; Antonini A; Bisiacchi P; Weis L; Biundo R
Mov Disord; 2021 Oct; 36(10):2303-2313. PubMed ID: 34124799
[TBL] [Abstract][Full Text] [Related]
9. Association between the LRP1B and APOE loci and the development of Parkinson's disease dementia.
Real R; Martinez-Carrasco A; Reynolds RH; Lawton MA; Tan MMX; Shoai M; Corvol JC; Ryten M; Bresner C; Hubbard L; Brice A; Lesage S; Faouzi J; Elbaz A; Artaud F; Williams N; Hu MTM; Ben-Shlomo Y; Grosset DG; Hardy J; Morris HR
Brain; 2023 May; 146(5):1873-1887. PubMed ID: 36348503
[TBL] [Abstract][Full Text] [Related]
10. The Genetic Drivers of Juvenile, Young, and Early-Onset Parkinson's Disease in India.
Andrews SV; Kukkle PL; Menon R; Geetha TS; Goyal V; Kandadai RM; Kumar H; Borgohain R; Mukherjee A; Wadia PM; Yadav R; Desai S; Kumar N; Joshi D; Murugan S; Biswas A; Pal PK; Oliver M; Nair S; Kayalvizhi A; Samson PL; Deshmukh M; Bassi A; Sandeep C; Mandloi N; Davis OB; Roberts MA; Leto DE; Henry AG; Di Paolo G; Muthane U; Das SK; Peterson AS; Sandmann T; Gupta R; Ramprasad VL;
Mov Disord; 2024 Feb; 39(2):339-349. PubMed ID: 38014556
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E Genotype Contributes to Motor Progression in Parkinson's Disease.
Pu JL; Jin CY; Wang ZX; Fang Y; Li YL; Xue NJ; Zheng R; Lin ZH; Yan YQ; Si XL; Chen Y; Liu Y; Song Z; Yan YP; Tian J; Yin XZ; Zhang BR
Mov Disord; 2022 Jan; 37(1):196-200. PubMed ID: 34612548
[TBL] [Abstract][Full Text] [Related]
12. Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease.
Bartl M; Dakna M; Schade S; Otte B; Wicke T; Lang E; Starke M; Ebentheuer J; Weber S; Toischer K; Schnelle M; Sixel-Döring F; Trenkwalder C; Mollenhauer B
Mov Disord; 2023 Jan; 38(1):68-81. PubMed ID: 36267007
[TBL] [Abstract][Full Text] [Related]
13. GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson's disease.
Senkevich K; Zorca CE; Dworkind A; Rudakou U; Somerville E; Yu E; Ermolaev A; Nikanorova D; Ahmad J; Ruskey JA; Asayesh F; Spiegelman D; Fahn S; Waters C; Monchi O; Dauvilliers Y; Dupré N; Greenbaum L; Hassin-Baer S; Grenn FP; Chiang MSR; Sardi SP; Vanderperre B; Blauwendraat C; Trempe JF; Fon EA; Durcan TM; Alcalay RN; Gan-Or Z
Brain; 2023 May; 146(5):1859-1872. PubMed ID: 36370000
[TBL] [Abstract][Full Text] [Related]
14. Predicting Ambulatory Capacity in Parkinson's Disease to Analyze Progression, Biomarkers, and Trial Design.
Venuto CS; Smith G; Herbst K; Zielinski R; Yung NCW; Grosset DG; Dorsey ER; Kieburtz K
Mov Disord; 2023 Oct; 38(10):1774-1785. PubMed ID: 37363815
[TBL] [Abstract][Full Text] [Related]
15. Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression.
Chohan H; Senkevich K; Patel RK; Bestwick JP; Jacobs BM; Bandres Ciga S; Gan-Or Z; Noyce AJ
Mov Disord; 2021 Jun; 36(6):1420-1429. PubMed ID: 33682937
[TBL] [Abstract][Full Text] [Related]
16. Lysosomal Polygenic Burden Drives Cognitive Decline in Parkinson's Disease with Low Alzheimer Risk.
Tunold JA; Tan MMX; Toft M; Ross O; van de Berg WDJ; Pihlstrøm L
Mov Disord; 2024 Mar; 39(3):596-601. PubMed ID: 38124396
[TBL] [Abstract][Full Text] [Related]
17. Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD).
Williams-Gray CH; Wijeyekoon R; Yarnall AJ; Lawson RA; Breen DP; Evans JR; Cummins GA; Duncan GW; Khoo TK; Burn DJ; Barker RA;
Mov Disord; 2016 Jul; 31(7):995-1003. PubMed ID: 26999434
[TBL] [Abstract][Full Text] [Related]
18. Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease.
Davis MY; Johnson CO; Leverenz JB; Weintraub D; Trojanowski JQ; Chen-Plotkin A; Van Deerlin VM; Quinn JF; Chung KA; Peterson-Hiller AL; Rosenthal LS; Dawson TM; Albert MS; Goldman JG; Stebbins GT; Bernard B; Wszolek ZK; Ross OA; Dickson DW; Eidelberg D; Mattis PJ; Niethammer M; Yearout D; Hu SC; Cholerton BA; Smith M; Mata IF; Montine TJ; Edwards KL; Zabetian CP
JAMA Neurol; 2016 Oct; 73(10):1217-1224. PubMed ID: 27571329
[TBL] [Abstract][Full Text] [Related]
19. Association of Rare Variants in ARSA with Parkinson's Disease.
Senkevich K; Beletskaia M; Dworkind A; Yu E; Ahmad J; Ruskey JA; Asayesh F; Spiegelman D; Fahn S; Waters C; Monchi O; Dauvilliers Y; Dupré N; Greenbaum L; Hassin-Baer S; Nagornov I; Tyurin A; Miliukhina I; Timofeeva A; Emelyanov A; Trempe JF; Zakharova E; Alcalay RN; Pchelina S; Gan-Or Z
Mov Disord; 2023 Oct; 38(10):1806-1812. PubMed ID: 37381728
[TBL] [Abstract][Full Text] [Related]
20. Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease.
Paul KC; Schulz J; Bronstein JM; Lill CM; Ritz BR
JAMA Neurol; 2018 Mar; 75(3):360-366. PubMed ID: 29340614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
